Replies to post #101 on Editas Medicine Inc (EDIT)

[jondoeuk]

Data at SITC. The poster is: Preclinical Development of EDIT-201, a Multiplexed CRISPR-Cas12a Gene Edited Healthy Donor Derived NK Cells Demonstrating Improved Persistence and Resistance to the Tumor Microenvironment